Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 19, 2026 09:00 ET | Source: MannKind

MannKind to Participate in the Oppenheimer 36th Annual Healthcare Life Sciences Conference

DANBURY, Conn. and WESTLAKE VILLAGE, Calif., Feb. 19, 2026 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), today announced Chief Executive Officer Michael Castagna, PharmD is...
February 19, 2026 08:30 ET | Source: BioMedWire

Drug-Delivery Breakthroughs, Cross-Indication Research Accelerate New Momentum in CNS and Oncology Development

AUSTIN, Texas, Feb. 19, 2026 (GLOBE NEWSWIRE) -- BioMedWire Editorial Coverage: Biotechnology mergers and acquisitions (M&As) are increasingly shaped by a clear strategic evolution....
February 19, 2026 08:00 ET | Source: MediWound Ltd.

MediWound to Report Fourth Quarter and Full Year 2025 Financial Results

Curtain Raiser for Q4 Earnings
February 19, 2026 07:00 ET | Source: AtaiBeckley N.V.

AtaiBeckley Appoints Michael Faerm as Chief Financial Officer

AtaiBeckley today announced the appointment of Michael Faerm as Chief Financial Officer, effective March 9, 2026.
February 19, 2026 07:00 ET | Source: Sitryx Therapeutics

Sitryx to present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference

Oxford, UK and Boston, MA – February 19, 2026 – Sitryx Therapeutics (“the Company”), a clinical-stage biopharmaceutical company developing novel oral therapies to restore immune balance in autoimmune...
February 18, 2026 09:33 ET | Source: Stoked Bio Inc.

Stoked Bio Secures Exclusive Global License to Develop a Promising New Therapy for Crohn’s Disease

Stoked Bio, a Canadian biotech company, will lead the development of Enterololin, a promising antibiotic, as a potential therapeutic for Crohn’s disease.
February 18, 2026 09:00 ET | Source: MannKind

MannKind to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026

DANBURY, Conn. and WESTLAKE VILLAGE, Calif., Feb. 18, 2026 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), a biopharmaceutical company dedicated to transforming chronic disease care through...
February 18, 2026 08:00 ET | Source: aTyr Pharma, Inc.

aTyr Pharma to Present at the Leerink Partners Global Healthcare Conference

aTyr Pharma to Present at the Leerink Partners Global Healthcare Conference
February 18, 2026 07:30 ET | Source: NervGen Pharma Corp.

NervGen Pharma to Participate at Upcoming Investor Conferences

VANCOUVER, British Columbia, Feb. 18, 2026 (GLOBE NEWSWIRE) -- NervGen Pharma Corp. (“NervGen” or the “Company") (TSXV: NGEN) (NASDAQ: NGEN), a clinical-stage biopharmaceutical company developing...
February 18, 2026 07:02 ET | Source: Ocugen

Ocugen to Host Conference Call on Wednesday, March 4, 2026 at 8:30 A.M. ET to Discuss Business Updates and Fourth Quarter and Full Year 2025 Financial Results

MALVERN, Pa., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced that...